XTX Topco’s Clearmind Medicine CMND Stock Holding History

XTX Topco’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-271	Closed	-$22.6K	–	4209
2026 Q1	$22.6K	Buy	+271	New	+$33.5K	﹤0.01%	3516
2025 Q3	–	Sell	-4	Closed	-$10.2K	–	2665
2025 Q2	$10.2K	Buy	+4	New	+$12.3K	﹤0.01%	2231

Other funds holding CMND

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

XTX Topco's CMND Position: Q2 2026 in Review

XTX Topco sold out of Clearmind Medicine (CMND) in Q2 2026, closing a stake of 271 shares — an estimated $22.6K sold.

XTX Topco first reported a position in CMND in Q2 2025 and held it in 2 quarters. The position peaked at $22.6K in Q1 2026. 5 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

XTX Topco reported no remaining Clearmind Medicine position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 271 Clearmind Medicine shares in Q2 2026, an estimated $22.6K.
XTX Topco first reported a position in Clearmind Medicine in Q2 2025 and held it in 2 quarters.
XTX Topco's Clearmind Medicine position peaked at $22.6K in Q1 2026.
5 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.